Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Case Series : Management of Elevated Lipoprotein(a) Using Double-Filtration Plasmapheresis (DFPP) in Hemodialysis Patients With Chronic Kidney Disease Clinical and Biological Outcomes in Patients at Cardiovascular and Thromboembolic Risk

NCT07390604 is registered in ClinicalTrials.gov with Centre Hospitalier Régional Metz-Thionville as lead sponsor.

NCT NCT07390604
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07390604 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Case Series : Management of Elevated Lipoprotein(a) Using Double-Filtration Plasmapheresis (DFPP) in Hemodialysis Patients With Chronic Kidney Disease Clinical and Biological Outcomes in Patients at Cardiovascular and Thromboembolic Risk
Lead sponsor
Centre Hospitalier Régional Metz-Thionville
Phase
Observational
Overall status
Completed
Start date
July 1, 2025
Completion date
December 31, 2025
Enrollment
5 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

double-filtration plasmapheresis, end stage chronic renal failure, hemodialysis complication, lipoprotein(a), lipoprotein-apheresis